to understand stem cell differentiation along multiple lineages, it is necessary to resolve heterogeneous cellular states and the ancestral relationships between them. We developed a robotic miniaturized cel-seq2 implementation to carry out deep single-cell rnA-seq of ~2,000 mouse hematopoietic progenitors enriched for lymphoid lineages, and used an improved clustering algorithm, raceid3, to identify cell types. to resolve subtle transcriptome differences indicative of lineage biases, we developed Fateid, an iterative supervised learning algorithm for the probabilistic quantification of cell fate bias in progenitor populations. here we used Fateid to delineate domains of fate bias and enable the derivation of highresolution differentiation trajectories, thereby revealing a common progenitor population of B cells and plasmacytoid dendritic cells, which we validated by in vitro differentiation assays. We expect that Fateid will improve understanding of the process of cell fate choice in complex multi-lineage differentiation systems.
Recent single-cell RNA-seq (scRNA-seq) [1] [2] [3] [4] [5] and single-cell lineage-tracing [6] [7] [8] studies call into question the traditional view of hematopoietic cell differentiation as a sequence of binary fate choices that shape a hierarchy of increasingly fate-restricted progenitor types 9 . Evidence from these studies suggests that early cell fate priming starts at the level of multipotent progenitors (MPPs) or even within the hematopoietic stem cell pool. The heterogeneity of lymphoid-biased progenitors has not been investigated on a large scale at single-cell resolution. Thus, we carried out an scRNA-seq analysis to reveal the heterogeneity of this population in the bone marrow of adult mice.
Although algorithms have been developed for lineage reconstruction [10] [11] [12] [13] , they are not designed to uncover subtle transcriptome changes or to account for multi-lineage bias in the assignment of cells to individual lineage branches. State-of-theart clustering methods also remain blind to weak transcriptome modulations. They partition cells into groups without accounting for the possible coexistence of multiple fate biases in individual cells. We argue that early transcriptional differences between cells both precede and influence ultimate fate specification. To elucidate the process of cell fate emergence, we developed FateID, a computational method for the quantification of fate bias manifested by subtle lineage-specific transcriptome modulations within a multipotent progenitor cell population. We show that FateID reliably detects fate bias in various multi-lineage differentiation systems and, in particular, elucidates lineage choice in lymphoid-biased hematopoietic progenitors.
results heterogeneity of hematopoietic progenitors in adult marrow
The detection of subtle transcriptome changes requires an scRNA-seq method that maximizes sensitivity and accuracy. Recent benchmarking has demonstrated that CEL-Seq2 (ref. 14) optimizes both of these factors, but it comes with high per-cell costs 15, 16 . To enable profiling of thousands of cells at low cost, we established an automated and miniaturized version of CEL-Seq2 on a Mosquito nanoliter-scale liquid-handling robot ( Fig. 1a and Online Methods; also see Supplementary Note 1 and Supplementary Fig. 1 ). Our Mosquito-CEL-Seq2 (mCEL-Seq2) protocol is compatible with single-cell sorting into 384-well plates and thus allows simultaneous recording of cell-surface marker expression by flow cytometry and measurement of single-cell transcriptomes by scRNA-seq. Compared with the original CEL-Seq2 protocol, mCEL-Seq2 allows up to tenfold volume reduction, with similar sensitivity and accuracy for five-, seven-, and tenfold reductions ( Supplementary Fig. 1a-e) .
To investigate the emergence of cell fate bias toward distinct lymphoid lineages, we sequenced 2,880 hematopoietic progenitors (Online Methods). We sorted these cells from overlapping progenitor populations on the basis of surface expression of Kit and Sca-1 (encoded by Ly6a), representing all major lineages of the hematopoietic tree ( Supplementary Fig. 2 ). We observed a wide distribution of transcript numbers per cell ranging from a median of 3,034 in common lymphoid progenitors (CLPs) to a median of 12,822 in MPPs (Supplementary Fig. 3a) .
A saturation analysis indicated that sequencing was not fully saturated, although it started to plateau ( Supplementary  Fig. 3b,c) . However, our transcriptome data showed high sensitivity compared with that of several recently published data sets on similar cell populations 1, 2, 17 ( Supplementary Fig. 3d,e) . We next discarded cells with <2,000 transcripts; this left 1,949 cell transcriptomes, which we analyzed with our RaceID3 algorithm, a substantially improved version of RaceID2 (ref. 18 ) (Online Methods).
A t-distributed stochastic neighbor embedding (t-SNE) map of single-cell transcriptomes showed that Lin − Sca-1 hi Kit hi (LSK) cells and lymphoid-primed multipotent progenitors (LMPPs) formed a big cloud, with CLPs and other small clusters in the periphery (Fig. 1b) . Cell-surface marker expression, quantified from intensities measured by index-sorting for a number of discriminative markers (Kit, Sca-1, Flt3, IL-7R, and Ly6d), delineated cells from the distinct sorting gates and showed moderate correlation with the mRNA levels for the respective markers ( Supplementary Fig. 3f-k) . pro-B (6, 10, 23) pre-B (5, 14, 15, 25, 32) pDC (12, 22) cDC (4, 19) NKT (13, 18) NK (24) ILC (31) Neutrophils (16, 17) Erythrocytes (9 
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To resolve heterogeneity within these populations, including for rare cell types, we carried out clustering analysis with outlier detection using RaceID3. The identified clusters discriminated subpopulations expressing marker genes of distinct lymphoid and myeloid lineages (Fig. 1c,d and Supplementary Fig. 4 Fig. 5 and Supplementary Note 2).
Fateid quantifies fate bias in hematopoietic progenitors
Our clustering analysis suggested the existence of population heterogeneity within the MPP compartment, which correlates with the observed expression of lineage-specific markers ( Fig. 1d and Supplementary Fig. 4) . However, clustering analysis is insensitive to subtle, gradual changes in gene expression that could indicate the onset of transcriptional priming toward distinct lineages. Moreover, clustering does not estimate the likelihood of a given cell differentiating toward each lineage.
To address this, we developed FateID, an iterative method that moves backward along differentiation trajectories from committed cell populations to quantify fate biases in individual progenitor cells. Committed cell populations ('target clusters') are initially identified by clustering or marker gene analysis. FateID uses random forests 23 to learn the identities of cells selected from the neighborhood of each target cluster: a defined number of cells from the target clusters that are most similar to the test set are used as a training set, to derive the probability that each cell in the test set belongs to any of the target clusters on the basis of random forest votes. Cells with a significant bias toward a particular lineage become part of the respective target cluster and are used for classification in the next iteration. FateID proceeds until the fate biases of all cells have been inferred (Fig. 2a and Online Methods).
We applied FateID to our hematopoietic progenitor data, using marker genes to identify the RaceID3 clusters corresponding to committed states of all lineages (Figs. 1d and 2b , and Online Methods) after removing outlier clusters with fewer than five cells. We compared FateID to the recently published STEMNET algorithm 2 . In the early progenitor clusters comprising LSK, LMPP, and CLP cells (clusters 1-3 and 7), FateID could discriminate subpopulations with pronounced fate bias toward B cells, pDCs, neutrophils, and erythrocytes ( Fig. 2c-f) . Neither FateID nor STEMNET could identify substantial fate bias for cDCs, NK cells, NKT cells, or innate lymphoid cells ( Supplementary Fig. 6a,b) , potentially because of the lack of intermediate progenitor stages of these lineages in our data sets. This is expected for cDCs, as they terminally differentiate in peripheral organs 24 , and our analysis might have picked up recirculating cells.
Fate bias, as quantified from the fraction of random forest votes for the respective target cluster, correlated with the expression of early lineage markers in progenitor clusters (Fig. 2c-f and Supplementary Fig. 6c-h) , such as Car2 for erythroblasts, Mpo for neutrophils and monocytes, Rag1 for B cells, and Irf8 for pDCs. Correlations derived with FateID were significantly higher than those derived with STEMNET for the majority of genes, and were comparable for the remaining genes (Fig. 2g) . Moreover, FateID had a larger dynamic range ( Supplementary  Fig. 6i-n) ; whereas STEMNET divides populations bimodally into cells with high bias and those with a finite baseline level of >10%, FateID assigns bias in a continuum from 0 to 1. Although STEMNET and FateID classified more mature stages equally well, STEMNET did not resolve early progenitor fate biases that are consistent with the expression of early markers and were observed by FateID. This is probably because STEMNET classifies progenitors solely on the basis of gene expression in mature cells. In contrast, the FateID training set moves backward along the differentiation trajectory with the cells to be classified and thus avoids classifying more naive cells solely on the basis of markers expressed at mature stages.
Finally, FateID permits the extraction of genes of high importance for classification in any iteration (Online Methods). Tracking relative importance along iterations highlights the relevance of a dynamic training set: markers of more mature stages are initially important, but early stages are classified by different sets of genes ( Fig. 3a and Supplementary Fig. 7a-e) . For example, B cell lineage analysis (Fig. 3a) started with cells in cluster 10 with high expression of genes related to B cell receptors and surrogate light chain components (Vpreb1, Vpreb3, and Igll1). These genes are most important for classification in initial iterations, whereas at earlier differentiation stages (later iterations) corresponding to pro-B cells, Pax5 and, even earlier, Ebf1 are important. Finally, among CLPs, recombination-associated genes such as Rag1 and Dntt are more important for classification. Thus, the feature importance as a function of the differentiation progress reveals stage-specific markers and uncovers the complexity of gene regulatory changes during differentiation.
In contrast to FateID's iterative strategy, classification in a single step resulted in a largely uniform fate-bias distribution across lineages within the multipotent compartment (Fig. 3b) .
To allow the purification of lineage-biased progenitors, we correlated the FateID bias predicted for each lineage to cell-surface marker expression as measured by index sorting ( Supplementary  Fig. 7f ). 25 , pDCs have mixed origins, with a substantial fraction (~26%) showing a history of Rag1 expression, suggesting partial lymphoid origin 26, 27 . A comparison of the fate bias for B cells (Fig. 2c) and pDCs ( Fig. 2e) showed that B cells arise from the Rag1 hi CLP compartment, whereas pDCs are predicted to arise from a progenitor pool encompassing Il7r + Rag1 lo CLPs and Il7r − LMPPs (Supplementary Fig. 3 ).
To further elucidate branching, we visualized the cell population in low dimensions using different algorithms provided in the FateID package ( Fig. 4a and Online Methods). We inferred pseudo-temporal ordering of B cell, myeloid, and pDC differentiation trajectories by fitting a principal curve to all cells with a fate bias of >15% for the respective lineage in a two-dimensional t-SNE map (Fig. 4a) . Topological ordering of z-score-transformed pseudo-temporal expression profiles identified stage-specific coexpression modules ( Fig. 4b and Supplementary Fig. 8a ). Known regulators of B cell differentiation such as the recombination-activating gene Rag1, the pre-B cell receptor component Igll1, and proliferation markers such as Pcna showed the expected pattern, reflecting heavy and light chain B cell receptor recombination with intermittent proliferation (Fig. 4b) . Pseudo-temporal ordering of dendritic cell progenitors recovered a gradual increase in Irf8 expression, already during early progenitor stages, and upregulation of known lineage-determining transcription factor genes such as Bst2 and Tcf4 at later stages ( Supplementary  Fig. 8a ). However, we observed that early progenitors upregulated Il7r to similar levels as B cell progenitors, but did not upregulate Rag1 to the same extent (Fig. 4c) . B cell progenitors were not observed to express Csf1r, but this gene was expressed in myeloid progenitors and, more stochastically, in progenitors with predicted pDC bias ( Supplementary Fig. 8b and Fig. 4c) . 
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To identify markers of subpopulations with dominant pDC or B cell bias within the lymphoid progenitor pool (clusters 2 and 7), we analyzed differential gene expression between groups of cells with >33% bias toward both pDCs and B cells, and higher bias toward B cells than pDCs, or vice versa (Fig. 4d) . We found that B-cell-biased progenitors showed upregulation of known B lineage genes (Ebf1, Pax5, Vpreb3, Rag1, and Cd79a) even at that early cell stage, whereas higher levels of Runx2, Irf8, Ncf1, Bcl2, and Cd34 were observed in pDC-biased progenitors. The increased importance of these genes during random-forest-based classification of the earlier stages is consistent with this observation (Fig. 3a and Supplementary Fig. 7b ).
Our analysis identified Cd34 as a marker that differentiates B cell and pDC bias in IL-7R + Flt3 + CLPs ( Supplementary  Fig. 8b) . Reassuringly, Ly6d, a previously described marker for B-cell-biased CLPs 28 , came up in our analysis. However, it is also expressed in more mature pDCs (Supplementary Fig. 8b ) and is therefore not ideal for separating B cell and pDC lineages. In conclusion, FateID predicted the existence of a common progenitor population of B cells and pDCs, and suggested differentiation toward pDCs as a prominent pathway in the lymphoid progenitor compartment.
For further validation, we applied FateID to published scRNAseq data for common myeloid progenitors 1 (Supplementary Note 3 and Supplementary Fig. 9 ) and intestinal epithelial cells 18 (Supplementary Note 4 and Supplementary Fig. 10 ). In contrast to Monocle 2 (ref. 29) (Supplementary Fig. 11 ), which applies fixed assignment of cells to unique branches, FateID uncovered multi-lineage bias in early progenitors that were not likely to have committed to a terminal fate. Finally, FateID analysis of a recently published human data set 2 suggested the existence of a conserved CLP population of pDCs and B cells in humans ( Supplementary  Fig. 12 and Supplementary Note 5).
In vitro confirmation of B cell and pdc progenitor population
To validate the emergence of both pDCs and B cells from a mouse CLP population, we sorted Flt3 + Lin − Kit lo Sca-1 lo cells and subgated on IL-7R + CD34 − , IL-7R + CD34 + , and IL-7R − CD34 + populations ( Fig. 5a and Supplementary Fig. 13 ). Flow cytometry analysis showed that these marker combinations alone are not sufficient to discriminate separate subpopulations, but rather represent distinct areas of a continuous population (Fig. 5a ). In addition, we sorted LMPPs as described under "Heterogeneity of hematopoietic progenitors in adult marrow". After culturing ~400 cells from each of these four populations on OP9 feeder cells in B cell or pDC medium for 7 d, we analyzed the relative B cell and pDC lineage output by measuring surface expression of CD19 and Siglec-H (Online Methods).
In agreement with the FateID predictions ( Fig. 2c,e) , IL-7R − CD34 + cells preferentially differentiated into Siglec-H + pDCs, and both IL-7R + CD34 + and IL-7R + CD34 − cells gave rise to Siglec-H + pDCs and CD19 + B cells. We did not observe cells positive for both CD19 and Siglec-H. As predicted by FateID, the fraction of pDCs was markedly reduced by 66% (37%) for IL-7R + CD34 − cells compared with that for IL-7R + CD34 + cells after culturing in B cell (pDC) medium (Fig. 5b,c) . We confirmed the purity of our input populations by scRNA-seq and analyzed these data together with scRNA-seq data from the cultured cells (Fig. 5d) . As expected, the sorted IL-7R − CD34 + and IL-7R + CD34 − input populations coclustered with mixed Flt3 + Lin − Kit lo Sca-1 lo cells but segregated into subpopulations positive for Il7r and Cd34 mRNA, respectively ( Fig. 5d,e) . In contrast, cultured cells separated into B cell, pDC, cDC, and lysozyme-expressing monocyte clusters (Fig. 5d,e) .
The emergence of monocytes from the IL-7R − CD34 + population is not surprising, as FateID predicted that pDC and monocyte/ neutrophil fate bias domains partially overlap (Fig. 2d,e ) and potentially could be separated on the basis of Flt3 expression ( Supplementary Fig. 3 ). The ratio of B cells to pDCs after culture as determined from scRNA-seq data was in agreement with the flow cytometry data and FateID predictions: IL-7R − CD34 + cells differentiated only into pDCs, whereas IL-7R + CD34 + and IL-7R + CD34 − cells gave rise to both lineages in culture, and IL-7R + CD34 − cell cultures yielded twice as many B cells as pDCs (Fig. 5f ). We point out that the sensitivity of the CD34 antibody we used is limited, and thus discrimination of CD34 + and CD34 − cells was not strictly quantitative. Moreover, we observed that B cell clones grew much more rapidly in culture than pDCs or monocytes. Therefore, although a strict quantitative comparison was not possible, the assay confirmed the FateID prediction of a CLP population of B cells and pDCs. discussion FateID revealed that the multipotent hematopoietic progenitor population segregates into subpopulations with dominant fate bias toward one of the major lineages, in agreement with previous studies suggestive of early fate priming 1, 2, 6 . In line with prior findings 6, 30, 31 , our predictions suggest that cells of megakaryocyte/ erythrocyte bias are closest to the MPP1/MPP2 compartment, Fig. 14a-c) . This order was also confirmed by StemID2 analysis (Supplementary Fig. 14d,e) .
Although our analysis suggests early priming, we detected domains of overlapping fate bias and validated a common progenitor population for pDCs and B cells: concomitant with upregulation of lymphoid genes such as Flt3, Dntt, and Il7r, cell bias toward the pDC lineage increased. Progenitors with myeloid and pDC biases still expressed markers of MPPs, such as Cd34; only after further downregulation of Cd34 and concomitant upregulation of Il7r and Rag1 did cells become more biased toward the B cell lineage. A picture emerges in which myeloid cells branch off first, followed by pDC progenitors, spanning a continuous spectrum from cells with alternative myeloid potential to cells with alternative lymphoid bias, and with ultimate branching of B cells. This is in line with previous studies that suggest mixed myeloid and lymphoid origins of pDCs 27, [33] [34] [35] [36] , and could help to resolve this controversy. Although our in vitro experiments could not determine bipotency of these progenitors, as this would require clonal analysis, our study sheds light on the origin of pDCs in the bone marrow, adding another piece to the puzzle of pDC versus cDC differentiation, which has been the subject of intense research 33, 34, [37] [38] [39] . As another example, we note that FateID recovered a recently characterized bipotent progenitor of monocytes and neutrophils 3 (Supplementary Fig. 15 ). 
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We have made all our data publicly available online (http:// hematopoietic-progenitors.ie-freiburg.mpg.de) to facilitate visualization of gene expression domains and fate bias together with differential gene expression analysis.
In summary, FateID reveals the heterogeneity of MPPs and links the underlying transcriptome modulations to lineage biases. These predictions shed light on the early regulators of cell fate choice and permit functional analysis of fate-biased subpopulations that can be isolated on the basis of de novo-identified marker genes. We envision that FateID will be a valuable tool for elucidating lineage choice in any multi-lineage differentiation system. methods Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
online methods
Mice. Five-week-old male C57BL/6J (wild-type) mice were purchased from Charles River or obtained from in-house breedings. Mice were kept in the animal facility of the Max Planck Institute of Immunobiology and Epigenetics under specific-pathogenfree conditions. Mice were killed in a carbon dioxide chamber, and femora and tibiae were collected. All animal experiments were performed in accordance with the relevant guidelines and regulations, approved by the review committee of the Max Planck Institute of Immunobiology and Epigenetics and the Regierungspräsidium Freiburg, Germany.
Single-cell sorting of hematopoietic progenitors. We isolated bone marrow from femora and tibiae of 5-week-old male C57BL/6J mice by flushing the bones with 1× MojoSort buffer (BioLegend; 480017). Bone marrow cells were filtered (CellTrics, 30 µm; Sysmex) and cells were counted (Innovatis CASY cell counter). We enriched hematopoietic progenitors by using the MojoSort mouse hematopoietic progenitor cell isolation kit (BioLegend; 480004) according to the manufacturer's protocol. Amplified RNA preparation from single cells. The CEL-Seq2 protocol, as previously described 14 , was adapted for use with a nanoliter pipetting robot (Mosquito HTS; TTP Labtech). We reduced the volumes used in the original protocol by fivefold for single-cell sorting of hematopoietic progenitors, but kept all the reagent ratios the same. Hematopoietic progenitors were sorted into 384-well plates (Corning; PCR-384-RGD-C). Every well was filled with 240 nl of lysis buffer. Lysis buffer was prepared using the following reagents, with final ratios shown in parentheses: 10 mM dNTP (1/12), 1:100,000 ERCC mix 1 or 2 (2/12), water with 0.35% Triton X-100 (7/12) and 25 ng/µl 1 out of 192 uniquely barcoded poly(dT) primers with a unique molecular identifier (UMI) (2/12). 1.2 µl of hydrophobic encapsulation barrier (Vapor-Lock; Qiagen; 981611) was added to the lysis buffer in every well. The sorted plates were incubated at 90 °C for 3 min and cooled to 4 °C thereafter. For cDNA firststrand synthesis, 160 nl of first-strand reaction mix containing SuperScript II reverse transcriptase and first-strand synthesis buffer (Invitrogen; 18064014) and RnaseOUT (Invitrogen; 10777019) was added, and the plates were incubated at 42 °C for 1 h and then subjected to heat inactivation at 70 °C for 10 min. Second-strand synthesis was carried out at 16 °C for 2 h and was initiated by the addition of 2,196 nl of second-strand reaction mix containing E. coli DNA polymerase I (Invitrogen; 18010025), Escherichia coli DNA ligase (Invitrogen; 18052019), RNase H (Invitrogen; 18021071) and second-strand buffer (Invitrogen; 10812014). For cDNA purification, 96 or 192 wells containing uniquely barcoded single-cell samples were pooled and 0.8 volumes of Agencourt AMPure XP beads (Beckman Coulter; A63881) were mixed with the pooled samples and incubated for 15 min at room temperature. The samples were put on a magnetic stand (96-well format) and incubated for 5 min, after which the supernatant was removed and the beads were washed twice with 180 µl of 80% ethanol and incubated for 40 s. The beads were dried for 10 min and resuspended in 7 µl of nucleasefree water (Invitrogen; AM9937). For the generation of amplified RNA (aRNA), 1.6 µl from each nucleotide solution (ATP, CTP, GTP, and UTP), 1.6 µl of 10× reaction buffer, and 1.6 µl of T7 enzyme from the MEGAscript T7 transcription kit (Invitrogen; AM1334) were added to the eluted cDNA and incubated at 37 °C for 13 h. After in vitro transcription, 6 µl of Exo-SAP-IT Express PCR product cleanup reagent (Applied Biosystems; 75001.1.ML) was added and the samples were incubated for another 15 min at 37 °C. Thereafter, aRNA was fragmented by the addition of 2.44 µl of 10× RNA fragmentation buffer and incubation at 94 °C for 3 min, and fragmentation was stopped by 2.44 µl of RNA Fragmentation Stop Solution (NEB; E6150S). For aRNA purification, 0.8 volumes of Agencourt RNAclean XP beads (Beckman Coulter; A63987) were added to the sample and incubated for 15 min at room temperature. After that, samples were placed on a magnetic stand and incubated for 5 min, the supernatant was removed, and the beads were washed three times by the addition of 180 µl of 70% ethanol and incubation for 40 s. Ethanol was removed, and beads were air-dried for 10 min and resuspended in 7 µl of nuclease-free water.
Single-cell library preparation from aRNA. The aRNA was reverse-transcribed to generate libraries for sequencing, as previously described 14 . We added 1 µl of custom random hexamer RT primer (GCCTTGGCACCCGAGAATTCCANNNNNN) and 0.5 µl of 10 mM dNTP to the aRNA. The samples were incubated at 65 °C for 5 min and cooled to 4 °C afterward. Then 4 µl of first-strand reaction mix containing SuperScript II reverse transcriptase and buffer (Invitrogen; 18064014) and RnaseOUT (Invitrogen; 10777019) was added and samples were incubated first at 25 °C for 10 min and then at at 42 °C for 1 h. To every sample, we added 2 µl of one uniquely indexed RPI index primer and 2 µl of RP1 primer (TruSeq Library Prep; sequences available from Illumina), 25 µl of Phusion high-fidelity PCR master mix with HF buffer (NEB; M0531), and 11 µl of nuclease-free water. PCR was carried out at 98 °C for 30 s for the initial step, followed by 11 cycles of amplification (98 °C for 10 s, 60 °C for 30 s, 72 °C for 30 s) and a final extension at 72 °C for 10 min. To each sample, 1 volume (50 µl) of Agencourt AMPure XP beads (Beckman Coulter; A63881) was added, and the samples were incubated at 25 °C for 15 min. The samples were incubated for 5 min on a magnetic stand (96-well format), the supernatant was removed, and the beads were washed twice by the addition of 180 µl of 80% ethanol and incubation for 40 s. Ethanol was removed and beads were dried for 10 min at room temperature. DNA was eluted with 25 µl of nuclease-free water, and the purification was repeated with an adjusted volume of magnetic beads (25 µl). After the final step the samples were eluted in 10 µl of nuclease-free water. DNA concentration and fragment size were determined with the Qubit dsDNA HS assay kit (Invitrogen; Q32854) and the Agilent high-sensitivity DNA kit for Bioanalyzer (Agilent Technologies; 5067-4627), respectively. Libraries were sequenced on an Illumina HiSeq 2500 system in high-output run mode at a depth of ~200,000 reads per cell.
Mouse embryonic stem cell culture. Mouse embryonic stem cells (mESCs) were cultured in KnockOut DMEM (Gibco; 10829018) supplemented with 15% KnockOut serum replacement (Gibco; 10828028), 1× nonessential amino acids (Gibco; 11140050), 1 mM sodium pyruvate (Gibco; 11360070), 1× GlutaMAX (Gibco; 35050061), 1× penicillin-streptomycin (Gibco; 10378016), 5 µg/ml insulin (Sigma; I0516), 100 µM 2-mercaptoethanol (Gibco; 31350010), and 1,000 U/ml LIF (Millipore; ESG1107). Medium was changed on a daily basis. Confluent cells were de-attached by incubation with trypsin-EDTA (Gibco; 25200056) at 37 °C for 5 min. mESCs were split every 3-5 d with 1:30-1:50 split ratios.
Single-cell library preparation for different volume reductions.
We maintained reagent ratios from the original CEL-Seq2 protocol for all the volume reductions. The protocol for different volume reductions was as described above, except that the volumes for the lysis buffer plate, first-strand synthesis, and secondstrand synthesis were adjusted. For every condition, 48 wells of a 384-well plate were prepared with 1.2 µl, 240 nl, 171 nl, or 120 nl of lysis buffer corresponding to onefold (original CEL-Seq2 volume), fivefold, sevenfold, or tenfold reductions, respectively. Every well contained 20 nl of 1:75,000 diluted ERCC mix 1. Lysis buffer was covered with a hydrophobic encapsulation barrier (Vapor-Lock; Qiagen; 981611). mESCs were harvested with trypsin-EDTA (see above) and single cells were sorted into each well with a BD Influx cell sorter. For first-strand synthesis we used adjusted volumes of 0.8 µl, 160 nl, 114 nl, and 80 nl of first-strand reaction mix for onefold, fivefold, sevenfold, and tenfold volume reductions, respectively. Second-strand synthesis was done with 11 µl, 2,196 nl, 1,569 nl, or 792 nl of second-strand reaction mix for the different volume reductions, respectively. The rest of the protocol was performed as described above.
Staining and sorting of hematopoietic progenitors for cell culture and single-cell sequencing. We isolated bone marrow from ilia, femora, and tibiae of 5-week-old male C57BL/6J mice by crushing the bones with 1× MojoSort buffer (BioLegend; 480017). Bone marrow cells were filtered (CellTrics, 30 µm; Sysmex) and cells were counted (Innovatis CASY cell counter). Hematopoietic progenitors were enriched with the MojoSort mouse hematopoietic progenitor cell isolation kit (BioLegend; 480004) according to the manufacturer's protocol. After enrichment, cells were counted again, and 5 × 10 6 to 7 × 10 6 cells per 100 µl of 1× MojoSort buffer were stained on ice in the dark for 40 min with antibodies to c-Kit/CD117 (BV510; BioLegend; 135119), Sca-1 (BV650; BioLegend; 108143), Flt3/CD135 (PerCP-eFluor 710; eBioscience; 46-1351-80), CD48 (APC/Fire 750; BioLegend; 103445), CD34 (PE; BD; 551387), Ly6d (Alexa Fluor 647; BD; 561147), IL-7Rα/CD127 (BV421; BD; 566377) and the lineage markers CD3e (FITC; BD; 553062), Ter119 (FITC; eBioscience; 11-5921-82), B220 (FITC; BD; 553088), Gr-1/Ly6g (FITC; BD; 553127), CD11b/Mac-1 (FITC; eBioscience; 11-0112-85), CD19 (FITC; BioLegend; 101505), and Siglec-H (FITC; BioLegend; 129603). The cells were sorted on a BD FACSAria Fusion cell sorter. For cell culture, cells from different gates (see "Single-cell sorting of hematopoietic progenitors") were sorted using fourway purity mode into 100 µl of RPMI 1640 medium (complete formulation; Thermo Fisher Scientific; A1049101) supplemented with 10% fetal calf serum (Corning BV; 35-016-CV), 1× penicillin-streptomycin (Gibco; 10378016), and 55 µM 2-mercaptoethanol (Gibco; 21985023). For single-cell sequencing, single cells were sorted in single-cell mode and index information was recorded. Cells were sorted into 384-well plates containing 240 nl of lysis buffer (see below) and 1.2 µl of hydrophobic encapsulation barrier (mineral oil; Sigma-Aldrich; M8410). After the single-cell sort, the plates were centrifuged at 2,200g at 4 °C for 10 min, snap-frozen with liquid nitrogen, and stored at −80 °C until they were processed using the downscaled version of CEL-Seq2 (mCEL-Seq2).
Cell culture of sorted hematopoietic progenitors. Sorted hematopoietic progenitors were seeded onto mitomycin-C-treated OP9 feeder cells. Approximately 400 cells were plated in 1 well of a 96-well plate and grown in 200 µl of medium at 37 °C and 5% CO 2 . For differentiation of the sorted progenitors toward plasmacytoid dendritic cells, we used RPMI 1640 medium (complete formulation; Thermo Fisher Scientific; A1049101) supplemented with 10% fetal calf serum (Corning BV; 35-016-CV), 1× penicillin-streptomycin (Gibco; 10378016), 55 µM 2-mercaptoethanol (Gibco; 21985023), and 200 ng/ml Flt3l (BioLegend; 550704).
To differentiate sorted cells toward the B cell lineage, we used Opti-MEM (Thermo Fisher Scientific; 31985062) supplemented with 10% fetal calf serum (Corning BV; 35-016-CV), 1× penicillin-streptomycin (Gibco; 10378016), 55 µM 2-mercaptoethanol (Gibco; 21985023), 5 ng/ml IL-7 (BioLegend; 577802), 10 ng/ml SCF (BioLegend; 579702), and 10 ng/ml Flt3l (BioLegend; 550704). On the day after sorting, we removed 100 µl of medium and replaced it with fresh medium. Every 2 d we replaced 100 µl of medium with fresh medium. The cells were grown for 7 d and then harvested for staining of lineage markers and sorting for single-cell sequencing. Preparation of OP9 feeder cell layer. OP9 feeder cells were grown in 1× MEM Alpha (Gibco; 12561-056) supplemented with 20% fetal calf serum (Corning BV; 35-016-CV), 1× penicillinstreptomycin (Gibco; 10378016), and 55 µM 2-mercaptoethanol (Gibco; 21985023). OP9 cells were grown until 80-90% confluent and treated with 10 µg/ml mitomycin C (Sigma-Aldrich; M0503-2MG) for 1.5 h. Cells were washed four times with PBS and detached with trypsin-EDTA (Gibco; 25200056) at 37 °C for 5 min. Cells were resuspended in fresh complete MEM Alpha medium, and cell concentration was adjusted to seed approximately 40,000-50,000 cells in 100 µl of medium per well of a 96-well plate.
Quantification of transcript abundance. Paired-end reads were aligned to the transcriptome using BWA (version 0.6.2-r126) with default parameters 40 . The transcriptome contained all gene models based on the mouse ENCODE VM9 release downloaded from the UCSC genome browser comprising 57,207 isoforms with 57,114 isoforms mapping to fully annotated chromosomes (1-19, X, Y, M). All isoforms of the same gene were merged to a single gene locus, and gene loci were merged to larger gene groups, if loci overlapped by >75%. This procedure resulted in 34,111 gene groups. The right mate of each read pair was mapped to the ensemble of all gene groups and to the set of 92 ERCC spike-ins in the sense direction. Reads mapping to multiple loci were discarded. The left mate contained the barcode information: the first six bases corresponding to the cellspecific barcode, followed by six bases representing the UMI. The remainder of the left read contained a poly(T) stretch and adjacent gene sequence. The left read was not used for quantification. For each cell barcode and gene locus, the number of UMIs was aggregated and, on the basis of binomial statistics, converted into transcript counts 41 .
RaceID3.
RaceID3 is an improved version of the previously published RaceID2 algorithm 18, 42 . In comparison to RaceID2, a number of additional optional steps have been implemented. A major change is the availability of a feature-selection step. If feature selection is enabled, genes will be selected with a variability exceeding the baseline variability as inferred by a second-order polynomial fit of the expression variance of all genes as a function of the mean after log-transformation. Only these genes will be used to compute the distance matrix used in the k-medoids clustering. For the outlier-identification step, all genes remaining after expression filtering are still used to rescue the identification of cell populations that were potentially missed due to the feature-selection step. A second major change is the introduction of a random-forest-based reclassification: after outlier identification, the robustness of the resulting partition is tested by random forest classification 23 , using the entire data set as the test set with out-of-bag sampling. The final cluster membership is subsequently determined as the cluster with the highest number of random forest votes.
RaceID3 also offers a number of normalization methods. The normalization by rescaling to the median transcript count in RaceID2 has been replaced by rescaling to the minimum total transcript number of all cells that survived the filtering, because the previous version led to inflated transcript counts in some cells and, subsequently, to false positive outlier cells. This method is now the default mode and is preferable to downsampling, as that comes with a loss of information. In addition, RaceID3 offers alternative normalization schemes, which are described in detail in the reference manual.
The improved algorithm further permits the elimination of unwanted variability. As a minimally invasive approach, signature genes of unwanted sources of variability, such as cell cycle or experimental batch, can be provided, and all genes with expression significantly correlated to one of these signature genes are removed for clustering and outlier identification.
As a second option, a PCA-based approach has been implemented. Expression data are log-transformed before PCA, and genes in the tail of the loading distribution for each principal component are screened for over-representation of defined sets of signature genes (e.g., annotated cell-cycle genes). If a significant over-representation is detected, the respective principal component is removed before back-transformation.
A third method eliminates unwanted sources of variability by linear regression. This method is akin to the limma method 43 and is particularly useful for the correction of batch effects.
To identify signature genes for each cluster, RaceID3 now infers differentially expressed genes by using an approach similar to DESeq 44 , but with a dispersion parameter of the negative binomials inferred from the internal background model.
Finally, we were able to substantially improve the run time compared with that for the previous version.
The RaceID3 and StemID2 algorithms are available at GitHub, along with a detailed reference manual (https://github.com/ dgrun/RaceID3_StemID2).
StemID2
. The logic of StemID2 remains unchanged compared with the original StemID algorithm. However, an alternative method for the inference of significant links of the lineage tree has been implemented to circumvent time-intense randomizations of the lineage tree and allow StemID to be run on data sets with thousands of cells. In this approach a large randomized distance matrix (with a number of cells equal to the size of the entire data set) is created only once for each cluster i and, keeping all cluster medoids the same as in the nonrandomized version, randomized cells are projected onto links between the medoid of cluster i and all clusters j ≠ i. The average population frequency of each link in the randomized state is then inferred from these projections and significant over-representation of cells on a link in the original data inferred by a binomial test requiring a minimum P value. Although this approach is much faster, it provides only an approximation of the actual significance, because the correlation of the population between links is neglected.
Functions for follow-up analysis of gene expression dynamics have also been integrated in StemID2. Pseudo-temporally ordered cells on a differentiation trajectory defined as a succession of significant links can be extracted to group the pseudo-temporal gene expression profiles into coexpression modules through the use of self-organizing maps. A similar approach is implemented in the FateID algorithm and described in the method section of that algorithm.
RaceID3 analysis of lymphoid cells, myeloid cells, and intestinal cells.
Prior to processing of mouse lymphoid progenitors by RaceID3, cells with high expression (>2% of all transcripts) of Kcnq1ot1, a previously identified marker of low-quality cells 18 , were removed. Moreover, transcripts correlating to Kcnq1ot1, Gm10715, Gm42418, or Gm10800 with a Pearson's correlation coefficient > 0.65 were also removed. Finally, all reads mapping to ERCC spike-ins were discarded. For the analysis of lymphoid progenitors, RaceID3 was run with mintotal = 2000, minexpr = 3, outminc = 3, FSelect = TRUE, probthr = 10 −4 and random-forest-based reclassification. For benchmarking, RaceID3 was run without random-forest-based reclassification to produce highresolution clustering with a greater number of outliers. In both cases, we initialized CGenes with the following set of genes to remove cell-cycle-and batch-associated variability: Pcna, Mki67, Ptma, Hsp90ab1, Actb, Jun, Fos, Gnas, and Hspa8. Batch signature genes were identified by analysis of differential gene expression between cells of different batches. FGenes was initialized with Malat1 and Igkc, as these genes had high expression across a number of unrelated cell types. For the myeloid progenitor data, we used the published quantification 1 and ran RaceID3 after downsampling with mintotal = 3000, CGenes = Hsp90ab1, minexpr = 5, outminc = 5, FSelect = TRUE, probthr = 10 −4 and random-forest-based reclassification. For the intestinal data, we used the published quantification 18 and ran RaceID3 with mintotal = 2000, minexpr = 3, outminc = 3, FSelect = TRUE, probthr = 10 −3 and random-forest-based reclassification. For human progenitors we applied RaceID3 to the published quantification 2 with mintotal = 10000, minexpr = 167, outminc = 167, FSelect = TRUE, probthr = 10 −3 . However, distances were computed with metric = "spearman," that is, Spearman's correlation was used instead of Pearson's correlation. This alleviated the effect of enhanced variability of the expression values, which corresponded to normalized read counts instead of UMI counts for this data set. On the basis of the saturation behavior of the within-cluster dispersion, a cluster number of 14 was chosen. CGenes was initialized with the following set of genes in order to remove cell-cycle-associated variability: PCNA, MKI67, MCM5, and MCM7. On mouse progenitor data from Olsson et al. 3 , RaceID3 was run with mintotal = 3000, minexpr = 5, outminc = 5, FSelect = TRUE, probthr = 10 −4 and random-forest-based reclassification.
Clustering methods for benchmarking of RaceID3. The Seurat algorithm 20 was run with the following parameters: min.cells = 3, min.genes = 200, normalization.method = "LogNormalize", and scale.factor = 10000. On the basis of the PC elbow plot, the first 15 principal components were used for clustering. To obtain predictions with different cluster numbers, we varied the resolution parameter (values: 1, 3, 6, 9, 12) . We ran the RCA 22 method in the SelfProjection mode after changing the upper_thresh parameter in the featureConstruct function to upper_thresh = max(log10(5), median(x[x > min_val])), because the original value was too large for UMI-based data. To obtain predictions with different cluster numbers, we varied the parameters deepSplit_wgcna (values: 1, 2, 3) and min_group_Size_wgcna (values: 3, 10). We ran SC3 (ref. 21 ) with 10, 20, 30, 40 , and 50 clusters to obtain predictions at varying sensitivity. ICGS 3 was run on non-normalized transcript counts with quantile normalization. We could not find a parameter that enabled control of the cluster number. RaceID3 was run with the parameters described elsewhere in the Online Methods and different values of the probability threshold probthr (values: 10 −2 , 10 −3 , 10 −4 , 10 −5 , 10 −6 ) to control the final cluster number.
FateID. The FateID algorithm performs an iterative calculation to infer fate bias in MPPs, starting from cells in committed states of the distinct lineages arising from a common progenitor. These states are addressed as target states, and it is expected that cells in each of these states do not exhibit mixed lineage signatures anymore. To run FateID, an expression matrix of all genes in all cells and a partitioning of cells into cell states or types are required. These cell states are expected to include all target states and at least one common state for all the remaining cells. However, finer partitions of the entire cell pool are also permitted, for example, as obtained from a clustering algorithm. In this case, the set of target states has to be defined as a subset of the partition. FateID also offers the possibility of inferring target states on the basis of the expression of a list of marker genes, with an arbitrary number of markers for each lineage. In this mode, FateID will compute the aggregated mean expression of the markers in the top n cells and select all cells with an aggregated marker gene expression greater than this threshold. This selection step is optionally followed by an initial random forest reclassification to test whether any of the remaining cells can be classified with high confidence as one of the target states. This step can also be used to perform feature selection by importance sampling (explained below).
Starting from the target states, FateID will proceed backward in differentiation time to iteratively learn progenitors of the target states by using random forest classification 23 . Briefly, the random forest method is an ensemble learning method that constructs a multitude of decision trees during learning and returns the mode of the classes for each instance across all trees. Owing to the inherent bootstrapping strategy (bagging) combined with random selection of features, random forests are robust to overfitting. The only adjustable parameter to which the results of random forests are somewhat sensitive is the number of features n sampled at each node. This number is kept constant across all decision trees and was also kept constant across FateID iterations. In this implementation it was set to the default value √M, where M is the number of features (i.e., genes).
The FateID algorithm uses random forests in the following way: in a given iteration, the training variables are the cells in the target states with transcript counts for all expressed genes as features. A prior feature selection for the entire data set accomplished, for example, by extraction of strongly variable genes, might enhance the performance of the algorithm. The response variable is the partition of the target states. Now, a fixed number of cells m in the neighborhood of each of the k target states is selected. For target state i, these cells are the m cells with the smallest median distance to the cells in state i, as measured by Pearson's correlation of the transcript count vectors of two cells. Alternatively, arbitrary distance matrices can be provided for this selection step. The set of k × m cells represents the test set for the random forest iteration. For the random forest classification, the training set can be reduced to h, the number of cells for each target state with the shortest distance to any of the cells in the test set selected for this target state. After classification, cells from the test set with a significant fate bias toward a given target state i, that is, those with significantly more votes for state i than for any other state (with significance defined as P < 0.05 on the basis of random counting statistics) are assigned to this target state for the next iteration. The algorithm proceeds this way until all cells have been tested.
By this strategy, cells populating early stages of differentiation are classified not solely on the basis of markers expressed in mature stages, but rather on the basis of markers of immediate subsequent stages of differentiation.
The number of cells to be selected for testing in each round (m) and the number of cells from each target state (h) are the two main parameters of the algorithms and should be chosen according to the coverage of the data set. Larger values of h provide higher confidence of the classification but also diminish the influence of the local neighborhood. Large data sets with sufficient coverage of all differentiation stages permit larger values of h.
The test set size m should be selected on the basis of similar considerations: large values decrease the running time, but could lead to decreased specificity when early progenitors are tested against distant mature stages. In practice, with the data sets of hundreds to thousands of cells presented in this paper, we used m = 5 and h = 20, but FateID was found to be very robust to changes in these parameters.
Extracting feature importance from FateID. The features that are relevant for classification in each random forest iteration are informative and include marker genes either enriched or depleted during progenitor stages of a given target state. The random forest classification is performed with importance sampling and thus returns for each gene the mean decrease in classification accuracy after permutation of this gene in each out-of-bag sample, as well as its respective s.d. FateID extracts all genes with importance greater than a selected threshold and an importance z-score (mean importance/s.d. of importance) exceeding another selected threshold. These genes are grouped by hierarchical clustering and displayed as a function of the iteration number, starting at the initial target state and ending at the most naive state. This strategy of data interrogation reveals the roles of different gene sets during subsequent stages of differentiation.
The fate bias for each cell is quantified from the fraction of votes for each of the target states and can thus be interpreted as a probability. We note that this probability is likely to be highly correlated to the actual probability of differentiation into the corresponding lineage, but will not be identical to this value, as external signals might modify a pre-existing bias.
The FateID algorithm is available as an R package with a detailed vignette from CRAN (package name: FateID), and from GitHub (https://github.com/dgrun/FateID).
Running FateID and STEMNET on hematopoietic progenitors, myeloid progenitors, and intestinal cells. For the mouse hematopoietic progenitors and the myeloid progenitors, FateID was run with minnr = 5 and minnrh = 20. For the intestinal data and the human hematopoietic progenitors, we chose minnr = 10, because the size of the data set was smaller, comprising only a few cells for some of the lineages. Intestinal target clusters were inferred by FateID, using the following list of marker genes: Alpi (enterocytes), Clca1 (goblet cells), Lyz1 (Paneth cells), Dclk1 (tuft cells), and Chgb (enteroendocrine cells). Target clusters for human hematopoietic cells were inferred by FateID, using the following list of marker genes: EBF1 (B cells), IRF8 (pDCs), LYZ (monocytes), ELANE (neutrophils), LMO4 (eosinophils/basophils/mast cells), HBB (erythrocytes), and ITGA2B (megakaryocytes). For the mouse hematopoietic progenitors and the myeloid progenitors, we selected the respective RaceID3 clusters as target clusters. STEMNET 2 was initialized with the same target clusters as FateID and run with default parameters. For data from Olsson et al. 3 , target clusters were inferred by FateID, using the following list of markers: Pf4 (megakaryocytes), Epor (erythrocytes), Cebpe (neutrophils), and Ly86 (monocytes); FateID was run with minnr = 5 and minnrh = 20.
Visualization of fate bias. FateID allows visualization of the data structure by a number of dimensional reduction representations, such as t-SNE 45 , classical multidimensional scaling, locally linear embedding, and diffusion maps 10 . These representations can be computed for dimensional reduction to an arbitrary number of dimensions k. For k = 2 or 3, these representations can be inspected directly, whereas for higher dimensions FateID permits visualization after projection on a subset of dimensions. In these representations FateID can highlight the partition, the expression of genes, or the fate bias to facilitate inspection of the results.
Inference of pseudo-temporal order and coexpression modules. To inspect gene expression dynamics during differentiation, FateID performs a topological ordering of pseudo-temporal expression profiles by self-organizing maps as described previously 18 . To obtain a pseudo-temporal order, all cells with a significant fate bias toward a given unique target state or, alternatively, all cells with a fate bias toward this state larger than a defined threshold are selected. These cells can be pseudo-temporally ordered by FateID by means of principal curve analysis within a selected dimensional reduction representation that best reflects the differentiation dynamics indicated by a gradient in the fate bias. The weight of the cells in the initial target cluster is increased tenfold to ensure that the principal curve traverses this set of cells, and an optional starting cluster can be provided to initialize the inference with a principal curve connecting this cluster with the initial target state. Alternatively, other methods such as diffusion pseudotime 10 can be used. FateID provides a direct interface to diffusion pseudotime ordering. For identification of modules of coexpressed genes along a differentiation trajectory to a defined target state, the expression levels in the pseudo-temporally ordered cells are smoothed by local regression after z-score transformation. These pseudo-temporal gene expression profiles are topologically ordered through computation of a one-dimensional self-organizing map with 1,000 nodes. Because of the large number of nodes relative to the number of clustered profiles, similar profiles are assigned to the same node. Only nodes with more than five assigned profiles are retained for visualization of coexpressed gene modules. Neighboring nodes with average profiles with a Pearson's correlation coefficient > 0.9 are merged with common gene expression modules. These modules are depicted in a final map.
Differential gene expression analysis. Genes with differential expression between two subgroups of cells were identified similarly to a previously published method 44 . First, we inferred a negative binomial distribution reflecting the gene expression variability within each subgroup based on a background model for the expected transcript count variability computed by the same strategy as in RaceID2 (ref. 18) . From these distributions, a P value for the observed difference in transcript counts between the two subgroups is computed as described for DESeq 44 . In the current study these P values were corrected for multiple testing via the Benjamini-Hochberg method.
Running Monocle2 on lymphoid progenitors. Monocle 2 (ref. 29 ) was run on non-normalized transcript counts with min_expr = 3 and num_cells_expressed ≥ 5. Cell types of the B cell, pDC, erythrocyte, neutrophil, cDC, and innate lymphoid lineages were assigned on the basis of expression of Ebf1, Siglech, Gata1, Elane, Cd74, and Thy1, with a minimum expression of 5 for all cell types but cDCs. For cDCs, at least 50 transcripts of Cd74 were required. For subsequent clustering, differentially expressed genes (qval < 0.01) were identified for each cell type, and the top 100 genes for each cell type were selected. Clustering was performed with eight clusters. Dimensions were reduced using the same set of genes as used for clustering with max_com-ponents = 2, norm_method = 'log' .
Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary.
Data availability. Primary read data and processed count files for the single-cell RNA-seq data sets of mouse hematopoietic cells reported in this paper can be downloaded from GEO (accession GSE100037). We make all our processed expression data publicly available online (http://hematopoietic-progenitors. ie-freiburg.mpg.de) to facilitate visualization of gene expression domains and fate bias together with differential gene expression analysis. Accession codes for the myeloid progenitor 1 and intestinal epithelial 18 single-cell transcriptome data can be found in the referenced studies. RaceID3 and StemID2 are available in the GitHub repository at https://github.com/dgrun/RaceID3_ StemID2. The FateID algorithm is available as an R package with a detailed vignette from CRAN (package name: FateID) and from GitHub (https://github.com/dgrun/FateID).
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Experimental design 1. Sample size
Describe how sample size was determined.
The number of mice (n=4) is in concordance with typical requirements for single cell sequencing experiments. Since data of different animals co-cluster in the cell type analysis n=4 animals are sufficient to demonstrate reproducibility. This is a typical sample size for single-cell RNA-seq experiments.
Data exclusions
Describe any data exclusions.
Prior to processing of mouse lymphoid pogenitors by RaceID3, cells with high expression (>2% of all transcripts) of Kcnq1ot1, a previously identified marker of low quality cells, were removed. Moreover, transcript correlating to Kcnq1ot1 or any of the genes Gm10715, Gm42418, Gm10800 with a Pearson's correlation coefficient >0.65 were also removed. Finally, all reads mapping to ERCC spike-ins were discarded. Cells with low total transcript number (<2,000) were excluded from the analysis. These cells likely arise from wells with reduced efficiency of amplification.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
Single-cell transcriptome data of n=4 different mice clustered together. For in vitro differentiation, five biological replicates were used, which is sufficient to reliably determine the lineage output.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Randomization was not applicable, since only mice of the same genotype were used. There was no comparison between groups.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was not applicable, since only mice of the same genotype were used. Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided Describe the software used to analyze the data in this study.
Algorithms written in R were used for data analysis. BWA was used for read mapping and a custom Perl script for the extraction of mRNA counts based on unique molecular identifiers. All R code was deposited on github. FateID is also available as an R package from CRAN. Further algorithms used for cluster benchmarking were ICGS/ AltAnalyze 2.0, Seurat 2. For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
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Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.
